Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Consensus Report on Management of Type 2 Diabetes Mellitus in Iran Publisher



Esteghamati A1 ; Malek M2 ; Ghasabeh FH3 ; Hadaegh F4 ; Afkhamiardekani M5 ; Meybodi HRA6 ; Dabbaghmanesh MH7 ; Ghaemi F8 ; Jahed SA9 ; Kalbasi S10 ; Mehrdad M11 ; Mousavi Z12 ; Niafar M13 ; Rezvanian H14 Show All Authors
Authors
  1. Esteghamati A1
  2. Malek M2
  3. Ghasabeh FH3
  4. Hadaegh F4
  5. Afkhamiardekani M5
  6. Meybodi HRA6
  7. Dabbaghmanesh MH7
  8. Ghaemi F8
  9. Jahed SA9
  10. Kalbasi S10
  11. Mehrdad M11
  12. Mousavi Z12
  13. Niafar M13
  14. Rezvanian H14
  15. Sanjari M15
  16. Ziaee A16
  17. Khamseh ME17
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  6. 6. Evidence-based Medicine Research Center, Endocrinology and Metabolism Clinical Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  8. 8. Department of Transplantation & Disease Management, Vice Curative, Ministry of Health and Medical Education (MOHME), Tehran, Iran
  9. 9. Gabric Diabetes Education Association, Tehran, Iran
  10. 10. Department of Endocrinology and Metabolism, School of Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  11. 11. Department of Endocrinology, Guilan University of Medical Sciences, Rasht, Iran
  12. 12. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  13. 13. Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  14. 14. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  15. 15. Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
  16. 16. Rasool Akram Medical Complex, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  17. 17. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran

Source: Medical Journal of the Islamic Republic of Iran Published:2025


Abstract

Background: Type 2 diabetes mellitus (T2DM) is one of the most serious public health problems all over the world. Development of local consensus on management of T2DM, providing clinicians, researchers, and policymakers with updated and valid evidence in consideration of practical issues, is crucial. Therefore, we aimed to develop a consensus report on management of T2DM in Iran. Methods: A task force group comprised of experts in diabetes management reviewed published literature. The task force members reached the majority agreement on all recommendations after participating in several group meeting discussions. Results: The consensus provided recommendations on diverse aspects on management of people with T2DM in Iran. The recommendations covered the following topics: first-line treatment, diabetes management in people with obesity, combination therapy in people with T2DM, injectable therapy, and non-alcoholic fatty liver in people with T2DM. Conclusion: Considering evidence-based guidelines, the task force group developed a consensus to address important clinical issues in the management of people with T2DM in Iran. Copyright © Iran University of Medical Sciences
Related Docs
1. Sglt2 Inhibitors and Ampk: The Road to Cellular Housekeeping?, Cell Biochemistry and Function (2024)
2. Safety, Efficacy, and Cardiovascular Benefits of Combination Therapy With Sglt-2 Inhibitors and Glp-1 Receptor Agonists in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Diabetology and Metabolic Syndrome (2025)
3. Comparative Effects of Different Macronutrient Compositions for Type 2 Diabetes Management: A Systematic Review and Network Meta-Analysis of Randomized Trials, Journal of Health, Population and Nutrition (2025)
Experts (# of related papers)
View all Related Experts
Shaban Alizadeh (1)
Kaveh Hosseini (1)